Single-cell analysis identifies PLK1 as a driver of immunosuppressive tumor microenvironment in LUAD
PLOS Genetics · 2024
DOI: 10.1371/journal.pgen.1011309 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Genetics, 2024. Verfasst von Yifan Kong und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky, United States of America. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Cell Cycle Proteins, Lung Neoplasms, Polo-Like Kinase 1. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS, NIH.
Abstract (Originalsprache)
PLK1 (Polo-like kinase 1) plays a critical role in the progression of lung adenocarcinoma (LUAD). Recent studies have unveiled that targeting PLK1 improves the efficacy of immunotherapy, highlighting its important role in the regulation of tumor immunity. Nevertheless, our understanding of the intricate interplay between PLK1 and the tumor microenvironment (TME) remains incomplete. Here, using genetically engineered mouse model and single-cell RNA-seq analysis, we report that PLK1 promotes an immunosuppressive TME in LUAD, characterized with enhanced M2 polarization of tumor associated macrophages (TAM) and dampened antigen presentation process. Mechanistically, elevated PLK1 coincides with increased secretion of CXCL2 cytokine, which promotes M2 polarization of TAM and diminishes expression of class II major histocompatibility complex (MHC-II) in professional antigen-presenting cells. Furthermore, PLK1 negatively regulates MHC-II expression in cancer cells, which has been shown to be associated with compromised tumor immunity and unfavorable patient outcomes. Taken together, our results reveal PLK1 as a novel modulator of TME in LUAD and provide possible therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky, United States of America.
- Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States of America.
- Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, Kentucky, United States of America.
- Department of Biostatistics, University of Kentucky, Lexington, Kentucky, United States of America.
ORCID-Profile: Derek B Allison, Daheng He, Xinyi Wang, Xiaoqi Liu
Förderung
- NCI NIH HHS
- NCATS NIH HHS
- NIH
Zitieren
APA
Kong, Y., Li, C., Liu, J., Wu, S., Zhang, M., Allison, D. B., Hassan, F., He, D., Wang, X., Mao, F., Zhang, Q., Zhang, Y., Li, Z., Wang, C., & Liu, X. (2024). Single-cell analysis identifies PLK1 as a driver of immunosuppressive tumor microenvironment in LUAD. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1011309
Vancouver
Kong Y, Li C, Liu J, Wu S, Zhang M, Allison DB, et al. Single-cell analysis identifies PLK1 as a driver of immunosuppressive tumor microenvironment in LUAD. PLOS Genetics. 2024. doi:10.1371/journal.pgen.1011309
BibTeX
@article{Kong2024,
author = {Kong, Yifan and Li, Chaohao and Liu, Jinpeng and Wu, Sai and Zhang, Min and Allison, Derek B and Hassan, Faisal and He, Daheng and Wang, Xinyi and Mao, Fengyi and Zhang, Qiongsi and Zhang, Yanquan and Li, Zhiguo and Wang, Chi and Liu, Xiaoqi},
title = {Single-cell analysis identifies PLK1 as a driver of immunosuppressive tumor microenvironment in LUAD},
journal = {PLOS Genetics},
year = {2024},
doi = {10.1371/journal.pgen.1011309}
}
EUVIMED